CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), today announced that David Schenkein, M.D., chief executive officer, will present at the Morgan Stanley Global Healthcare conference on Wednesday, September 11, 2013 at 11:45 a.m. ET in New York City.
A live webcast of Agios’ presentation can be accessed by visiting the investors section of the company’s website at investor.agios.com. A replay of the webcast will be archived on the Agios website for two weeks following the presentation.
About Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals is focused on discovering and developing novel drugs to treat cancer and rare metabolic genetic diseases (known as inborn errors of metabolism or IEMs) through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across both therapeutic areas, Agios has multiple first-in-class lead product candidates in cancer metabolism and IEMs advancing toward the clinic. All Agios programs focus on genetically identified patient populations leveraging our knowledge of metabolism, biology and genomics. For more information, please visit our website at www.agios.com.